Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Gustavo Olivera PhD

Advertisement

Articles by Gustavo Olivera PhD

Daily and Cumulative Dose Recalculation and in Vivo Verification for Helical TomoTherapy: Multicenter Validation

ByGustavo Olivera PhD,Xiaohu Mo MS,Don Parnell CMD,Stephanie Key CMD,Constantine Mantz, MD,Eduardo Fernandez MD, PhD,Daniel Dosoretz MD,Arie Dosoretz MD,Larry Kestin MD,Alvaro Martinez, MD,Steven E. Finkelstein, MD
June 13th 2015

Rapid advances in the technological development of precise and conformal radiation therapy and its incorporation into the clinic have generally outpaced our ability to test these technologies in a clinical trial format.

Gustavo Olivera, PhD, Discusses an Analysis of a Radiation Oncology Registry

ByGustavo Olivera PhD
September 23rd 2014

Gustavo Olivera, PhD, from 21st Century Oncology, discusses an analysis of a radiation oncology registry.

Advertisement

Latest Updated Articles

  • Gustavo Olivera, PhD, Discusses an Analysis of a Radiation Oncology Registry
    Gustavo Olivera, PhD, Discusses an Analysis of a Radiation Oncology Registry

    September 23rd 2014

  • Daily and Cumulative Dose Recalculation and in Vivo Verification for Helical TomoTherapy: Multicenter Validation
    Daily and Cumulative Dose Recalculation and in Vivo Verification for Helical TomoTherapy: Multicenter Validation

    June 13th 2015



Advertisement
Advertisement

Trending on OncLive

1

Revisit Every OncLive On Air Episode From June 2026

2

FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC

3

FDA Flashback: Breast Cancer Decisions and News From June 2026

4

Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC

5

Risvutatug Rezetecan Shows OS Benefit Over Topotecan in Relapsed SCLC

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us